diagnostic procedures associated with the use of 
such drugs, and clinical follow up and moni-
toring, including any related services rec-
ommended in current United States Public 
Health Service clinical practice guidelines, with-
out limitation.’’. 
(B) ELIMINATION OF COINSURANCE.—Sec-
tion 1833(a)(1) of the Social Security Act (42 
U.S.C. 1395l(a)(1)) is amended— 
(i) by striking ‘‘and (CC)’’ and insert-
ing ‘‘(CC)’’; and 
(ii) by inserting before the semicolon 
at the end the following:‘‘ , and (DD) with 
respect to preventive services described in 
subparagraph (D) of section 1861(ddd)(3), 
the amount paid shall be 100 percent of (i) 
except as provided in clause (ii), the lesser 
of the actual charge for the service or the 
amount determined under the fee schedule 
that applies to such treatment under this 
part, and (ii) in the case of such services 
that are covered OPD services (as defined 
in subsection (t)(1)(B)), the amount deter-
mined under subsection (t)’’. 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
(C) EXEMPTION FROM PART B DEDUCT-
IBLE.—Section 1833(b) of the Social Security 
Act (42 U.S.C. 1395l(b)) is amended— 
(i) in paragraph (9), by striking 
‘‘and’’ at the end; and 
(ii) in paragraph (10), by striking the 
period at the end and inserting ‘‘, and (11) 
such deductible shall not apply with re-
spect to preventive services described in 
subparagraph 
(D) 
of 
section 
1861(ddd)(3).’’. 
(D) EFFECTIVE DATE.—The amendments 
made by this paragraph shall apply to items 
and services furnished on or after January 1, 
2021. 
(2) PART D.— 
(A) IN GENERAL.—Section 1860D–2(b) of 
the Social Security Act (42 U.S.C. 1395w– 
102(b)) is amended— 
(i) in paragraph (1)(A), by striking 
‘‘The coverage’’ and inserting ‘‘Subject to 
paragraph (8), the coverage’’; 
(ii) in paragraph (2)(A), by striking 
‘‘and (D)’’ and inserting ‘‘and (D) and 
paragraph (8)’’; 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
(iii) in paragraph (3)(A), by striking 
‘‘and (4)’’ and inserting ‘‘(4), and (8)’’; 
(iv) in paragraph (4)(A)(i), by strik-
ing ‘‘The coverage’’ and inserting ‘‘Subject 
to paragraph (8), the coverage’’; and 
(v) by adding at the end the following 
new paragraph: 
‘‘(8) LIMITATIONS
ON
COST-SHARING
FOR 
DRUGS
FOR
THE
PREVENTION
OF
HIV
ACQUISI-
TION.— 
‘‘(A) IN GENERAL.—For plan year 2021 
and each subsequent plan year, there shall be 
no cost-sharing under this part (including 
under section 1814D–14) for covered part D 
drugs that are for the prevention of HIV acqui-
sition. 
‘‘(B) COST-SHARING.—For purposes of 
subparagraph (A), the elimination of cost-shar-
ing shall include the following: 
‘‘(i) NO
APPLICATION
OF
DEDUCT-
IBLE.—The waiver of the deductible under 
paragraph (1). 
‘‘(ii) NO
APPLICATION
OF
COINSUR-
ANCE.—There waiver of coinsurance under 
paragraph (2). 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
‘‘(iii) NO
APPLICATION
OF
INITIAL 
COVERAGE
LIMIT.—The initial coverage 
limit under paragraph (3) shall not apply. 
‘‘(iv) NO COST SHARING ABOVE AN-
NUAL OUT-OF-POCKET THRESHOLD.—The 
waiver of cost sharing under paragraph 
(4).’’. 
(B) CONFORMING AMENDMENTS TO COST 
SHARING FOR LOW-INCOME INDIVIDUALS.—Sec-
tion 1860D–14(a) of the Social Security Act 
(42 U.S.C. 1395w–114(a)) is amended— 
(i) in paragraph (1), in the matter 
preceding subparagraph (A), by striking 
‘‘In the case’’ and inserting ‘‘Subject to 
section 1860D–2(b)(8), in the case’’; and 
(ii) in paragraph (2), in the matter 
preceding subparagraph (A), by striking 
‘‘In the case’’ and inserting ‘‘Subject to 
section 1860D–2(b)(8), in the case’’. 
(f) COVERAGE OF HIV PREVENTION TREATMENT BY 
DEPARTMENT OF VETERANS AFFAIRS.— 
(1) ELIMINATION
OF
MEDICATION
COPAY-
MENTS.—Section 1722A(a) of title 38, United 
States Code, is amended by adding at the end the 
following new paragraph: 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
‘‘(5) Paragraph (1) does not apply to a medication 
for the prevention of HIV acquisition.’’. 
(2) ELIMINATION OF HOSPITAL CARE AND MED-
ICAL SERVICES COPAYMENTS.—Section 1710 of such 
title is amended— 
(A) in subsection (f)— 
(i) by redesignating paragraph (5) as 
paragraph (6); and 
(ii) by inserting after paragraph (4) 
the following new paragraph (5): 
‘‘(5) A veteran shall not be liable to the United States 
under this subsection for any amounts for laboratory and 
other diagnostic procedures associated with the use of any 
prescription drug approved by the Food and Drug Admin-
istration for the prevention of HIV acquisition, or for lab-
oratory or other diagnostic procedures associated with the 
use of such drugs, or clinical follow up and monitoring, 
including any related services recommended in current 
United States Public Health Service clinical practice 
guidelines, without limitation.’’; and 
(B) in subsection (g)(3), by adding at the 
end the following new subparagraph: 
‘‘(C) Any prescription drug approved by the 
Food and Drug Administration for the prevention of 
HIV acquisition, laboratory and other diagnostic 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS
procedures associated with the use of such drugs, 
and clinical follow up and monitoring, including any 
related services recommended in current United 
States Public Health Service clinical practice guide-
lines, without limitation.’’. 
(3) INCLUSION AS PREVENTIVE HEALTH SERV-
ICE.—Section 1701(9) of such title is amended— 
(A) in subparagraph (K), by striking ‘‘; 
and’’ and inserting a semicolon; 
(B) by redesignating subparagraph (L) as 
subparagraph (M); and 
(C) by inserting after subparagraph (K) 
the following new subparagraph (L): 
‘‘(L) any prescription drug approved by 
the Food and Drug Administration for the pre-
vention of HIV acquisition, laboratory and 
other diagnostic procedures associated with the 
use of such drugs, and clinical follow up and 
monitoring, including any related services rec-
ommended in current United States Public 
Health Service clinical practice guidelines, with-
out limitation; and’’. 
(g) COVERAGE OF HIV PREVENTION TREATMENT BY 
DEPARTMENT OF DEFENSE.— 
VerDate Sep 11 2014 
04:29 Aug 01, 2019
Jkt 089200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H3815.IH
H3815
kjohnson on DSK79L0C42 with BILLS